Cargando…

MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death in the world. Mitochondrial fission regulator 2 (MTFR2) is involved in the development of various cancers. However, the roles of MTFR2 in HCC remain unknown. In this study, we conducted a comprehensive analysis of MTFR2 in HCC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Qiaoqiao, Han, Ying, Shen, Edward, Feng, Ziyang, Peng, Yinghui, Gao, Le, Gao, Yan, Liu, Yongting, Li, Wei, Liu, Ping, Chen, Yihong, Guo, Cao, Zeng, Shan, Cai, Changjing, Shen, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881049/ https://www.ncbi.nlm.nih.gov/pubmed/36713263 http://dx.doi.org/10.1016/j.isci.2022.105095

Ejemplares similares

Hsa_Circ_0066351 Acts as a Prognostic and Immunotherapeutic Biomarker in Colorectal Cancer
por: Gao, Yan, et al.
Publicado: (2022)

Prognostic stratification based on m(5)C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma
por: Liu, Ping, et al.
Publicado: (2022)

A comprehensive analysis of the efficacy and safety of COVID-19 vaccines
por: Cai, Changjing, et al.
Publicado: (2021)

Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model
por: Cai, Changjing, et al.
Publicado: (2022)

A Multi-Omics Analysis of NASH-Related Prognostic Biomarkers Associated with Drug Sensitivity and Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Yongting, et al.
Publicado: (2023)

Low expression of NLRP1 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients
por: Shen, Edward, et al.
Publicado: (2021)

A multi-omics analysis reveals CLSPN is associated with prognosis, immune microenvironment and drug resistance in cancers
por: Chen, Yihong, et al.
Publicado: (2023)

The optimal first-line treatment for patients with left-sided RAS wild-type metastatic colorectal cancer: Double-drug regimen or triple-drug regimen therapy
por: Cai, Changjing, et al.
Publicado: (2022)

tRF3008A suppresses the progression and metastasis of colorectal cancer by destabilizing FOXK1 in an AGO-dependent manner
por: Han, Ying, et al.
Publicado: (2022)

A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer
por: Qin, Yiming, et al.
Publicado: (2023)

M6A “Writer” Gene METTL14: A Favorable Prognostic Biomarker and Correlated With Immune Infiltrates in Rectal Cancer
por: Cai, Changjing, et al.
Publicado: (2021)

Overexpression of MTFR2 Predicts Poor Prognosis of Breast Cancer
por: Lu, Wenjie, et al.
Publicado: (2020)

Prognostic Value and Potential Mechanism of MTFR2 in Lung Adenocarcinoma
por: Lian, Zengzhi, et al.
Publicado: (2022)

AMPK-dependent phosphorylation of MTFR1L regulates mitochondrial morphology
por: Tilokani, Lisa, et al.
Publicado: (2022)

RASGRP2 is a potential immune-related biomarker and regulates mitochondrial-dependent apoptosis in lung adenocarcinoma
por: Liu, Yongting, et al.
Publicado: (2023)

Pan-Cancer and Single-Cell Analysis Reveals CENPL as a Cancer Prognosis and Immune Infiltration-Related Biomarker
por: Feng, Ziyang, et al.
Publicado: (2022)

Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics
por: Chen, Cheng, et al.
Publicado: (2021)

AMICA1 is a diagnostic and prognostic biomarker and induces immune cells infiltration by activating cGAS-STING signaling in lung adenocarcinoma
por: Feng, Ziyang, et al.
Publicado: (2022)

MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her‐2/PI3K/AKT Signaling
por: Han, Ying, et al.
Publicado: (2020)

MTFR2 Promotes the Proliferation, Migration, and Invasion of Oral Squamous Carcinoma by Switching OXPHOS to Glycolysis
por: Wang, Wei, et al.
Publicado: (2020)

Mitochondrial fission regulator 2 (MTFR2) promotes growth, migration, invasion and tumour progression in breast cancer cells
por: Lu, Guanming, et al.
Publicado: (2019)

CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma
por: He, Min, et al.
Publicado: (2021)

Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality
por: Cai, Changjing, et al.
Publicado: (2021)

Correction for: Mitochondrial fission regulator 2 (MTFR2) promotes growth, migration, invasion and tumour progression in breast cancer cells
por: Lu, Guanming, et al.
Publicado: (2020)

Negatively Regulated by miR-29c-3p, MTFR1 Promotes the Progression and Glycolysis in Lung Adenocarcinoma via the AMPK/mTOR Signalling Pathway
por: Li, Yongmeng, et al.
Publicado: (2021)

From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
por: Fu, Yaojie, et al.
Publicado: (2019)

Transcription factor HOXC10 activates the expression of MTFR2 to regulate the proliferation, invasion and migration of colorectal cancer cells
por: Xie, Ying, et al.
Publicado: (2021)

NFAT4-dependent miR-324-5p regulates mitochondrial morphology and cardiomyocyte cell death by targeting Mtfr1
por: Wang, K, et al.
Publicado: (2015)

Corrigendum: Negatively regulated by miR-29c-3p, MTFR1 promotes the progression and glycolysis in lung adenocarcinoma via the AMPK/mTOR signalling pathway
por: Li, Yongmeng, et al.
Publicado: (2022)

A comprehensive analysis of the fatal toxic effects associated with CD19 CAR-T cell therapy
por: Cai, Changjing, et al.
Publicado: (2020)

MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and Experiments
por: Zhu, Hai, et al.
Publicado: (2021)

FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer
por: Chen, Yihong, et al.
Publicado: (2020)

The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma
por: Deng, Ganlu, et al.
Publicado: (2017)

The efficacy of COVID-19 vaccines against the B.1.617.2 (delta) variant
por: Cai, Changjing, et al.
Publicado: (2021)

Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as potential predictive markers of treatment response in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
por: Rugambwa, Tibera K., et al.
Publicado: (2023)

BMP4 promotes hepatocellular carcinoma proliferation by autophagy activation through JNK1-mediated Bcl-2 phosphorylation
por: Deng, Ganlu, et al.
Publicado: (2018)

Which cancer type has the highest risk of COVID-19 infection?
por: Cai, Changjing, et al.
Publicado: (2020)

In respond to commensal bacteria: γδT cells play a pleiotropic role in tumor immunity
por: Liu, Yongting, et al.
Publicado: (2021)

Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
por: Huang, Changjing, et al.
Publicado: (2021)

Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma
por: Xia, Yujia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fi6q7b8e8vlckcuj4vbkdvh3r6